Table of Content

Chapter 1: INTRODUCTION
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits to the Stakeholders
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
Chapter 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
Chapter 3: MARKET OVERVIEW
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Impacting Factors
3.2.2. Top Investment Pockets
3.3. Porter’s Five Forces Analysis
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
3.5. COVID-19 Impact Analysis on the market
Chapter 4: CHINA RADIOPHARMACEUTICALS MARKET, BY RADIOISOTOPE
4.1. Overview
4.1.1. Market Size and Forecast, By Radioisotope
4.2. Technetium 99m
4.3. Fluorine 18
4.4. Iodine I
4.5. Gallium 68
4.6. Others
Chapter 5: CHINA RADIOPHARMACEUTICALS MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market Size and Forecast, By Application
5.2. Cancer
5.3. Cardiology
5.4. Others
Chapter 6: CHINA RADIOPHARMACEUTICALS MARKET, BY TYPE
6.1. Overview
6.1.1. Market Size and Forecast, By Type
6.2. Diagnostic
6.3. Therapeutic
Chapter 7: CHINA RADIOPHARMACEUTICALS MARKET, BY END USER
7.1. Overview
7.1.1. Market Size and Forecast, By End User
7.2. Hospitals and clinics
7.3. Medical Imaging centers
7.4. Others
Chapter 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top player positioning, 2022
Chapter 9: COMPANY PROFILES
9.1. IBA Molecular (Belgium)
9.1.1. Company overview
9.1.2. Key Executives
9.1.3. Company snapshot
9.1.4. Operating business segments
9.1.5. Product portfolio
9.1.6. Business performance
9.1.7. Key strategic moves and developments
9.2. AECI Nuclear Products (South Africa)
9.2.1. Company overview
9.2.2. Key Executives
9.2.3. Company snapshot
9.2.4. Operating business segments
9.2.5. Product portfolio
9.2.6. Business performance
9.2.7. Key strategic moves and developments
9.3. Institute of Radiopharmaceuticals (China)
9.3.1. Company overview
9.3.2. Key Executives
9.3.3. Company snapshot
9.3.4. Operating business segments
9.3.5. Product portfolio
9.3.6. Business performance
9.3.7. Key strategic moves and developments
9.4. Beijing Beigene Molecular Probes Co Ltd (China)
9.4.1. Company overview
9.4.2. Key Executives
9.4.3. Company snapshot
9.4.4. Operating business segments
9.4.5. Product portfolio
9.4.6. Business performance
9.4.7. Key strategic moves and developments
9.5. Sinopharm Pharmaceuticals (China)
9.5.1. Company overview
9.5.2. Key Executives
9.5.3. Company snapshot
9.5.4. Operating business segments
9.5.5. Product portfolio
9.5.6. Business performance
9.5.7. Key strategic moves and developments
9.6. Shanghai Institute of Materia Medica (China)
9.6.1. Company overview
9.6.2. Key Executives
9.6.3. Company snapshot
9.6.4. Operating business segments
9.6.5. Product portfolio
9.6.6. Business performance
9.6.7. Key strategic moves and developments
9.7. Guangzhou Yeed Medical Technology Co Ltd (China)
9.7.1. Company overview
9.7.2. Key Executives
9.7.3. Company snapshot
9.7.4. Operating business segments
9.7.5. Product portfolio
9.7.6. Business performance
9.7.7. Key strategic moves and developments
9.8. Shanghai Pharmaceutical Group Co Ltd (China)
9.8.1. Company overview
9.8.2. Key Executives
9.8.3. Company snapshot
9.8.4. Operating business segments
9.8.5. Product portfolio
9.8.6. Business performance
9.8.7. Key strategic moves and developments
9.9. CSPC Pharmaceutical Group (China)
9.9.1. Company overview
9.9.2. Key Executives
9.9.3. Company snapshot
9.9.4. Operating business segments
9.9.5. Product portfolio
9.9.6. Business performance
9.9.7. Key strategic moves and developments
9.10. Jubilant Biosys (India)
9.10.1. Company overview
9.10.2. Key Executives
9.10.3. Company snapshot
9.10.4. Operating business segments
9.10.5. Product portfolio
9.10.6. Business performance
9.10.7. Key strategic moves and developments



List of Figures

LIST OF FIGURES
FIGURE 01. CHINA RADIOPHARMACEUTICALS MARKET, 2022-2032
FIGURE 02. SEGMENTATION OF CHINA RADIOPHARMACEUTICALS MARKET, 2022-2032
FIGURE 03. TOP INVESTMENT POCKETS IN CHINA RADIOPHARMACEUTICALS MARKET (2023-2032)
FIGURE 04. PORTER FIVE-1
FIGURE 05. PORTER FIVE-2
FIGURE 06. PORTER FIVE-3
FIGURE 07. PORTER FIVE-4
FIGURE 08. PORTER FIVE-5
FIGURE 09. DRIVERS, RESTRAINTS AND OPPORTUNITIES: CHINA RADIOPHARMACEUTICALS MARKET
FIGURE 10. CHINA RADIOPHARMACEUTICALS MARKET,BY RADIOISOTOPE, 2022 ($MILLION)
FIGURE 11. CHINA RADIOPHARMACEUTICALS MARKET,BY APPLICATION, 2022 ($MILLION)
FIGURE 12. CHINA RADIOPHARMACEUTICALS MARKET,BY TYPE, 2022 ($MILLION)
FIGURE 13. CHINA RADIOPHARMACEUTICALS MARKET,BY END USER, 2022 ($MILLION)
FIGURE 14. TOP WINNING STRATEGIES, BY YEAR
FIGURE 15. TOP WINNING STRATEGIES, BY DEVELOPMENT
FIGURE 16. TOP WINNING STRATEGIES, BY COMPANY
FIGURE 17. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 18. COMPETITIVE DASHBOARD
FIGURE 19. COMPETITIVE HEATMAP: CHINA RADIOPHARMACEUTICALS MARKET
FIGURE 20. TOP PLAYER POSITIONING, 2022
FIGURE 21. IBA MOLECULAR (BELGIUM): NET SALES, 2020-2022*?($MILLION)
FIGURE 22. IBA MOLECULAR (BELGIUM): REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 23. IBA MOLECULAR (BELGIUM): REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 24. AECI NUCLEAR PRODUCTS (SOUTH AFRICA): NET SALES, 2020-2022*?($MILLION)
FIGURE 25. AECI NUCLEAR PRODUCTS (SOUTH AFRICA): REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 26. AECI NUCLEAR PRODUCTS (SOUTH AFRICA): REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 27. INSTITUTE OF RADIOPHARMACEUTICALS (CHINA): NET SALES, 2020-2022*?($MILLION)
FIGURE 28. INSTITUTE OF RADIOPHARMACEUTICALS (CHINA): REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 29. INSTITUTE OF RADIOPHARMACEUTICALS (CHINA): REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 30. BEIJING BEIGENE MOLECULAR PROBES CO LTD (CHINA): NET SALES, 2020-2022*?($MILLION)
FIGURE 31. BEIJING BEIGENE MOLECULAR PROBES CO LTD (CHINA): REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 32. BEIJING BEIGENE MOLECULAR PROBES CO LTD (CHINA): REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 33. SINOPHARM PHARMACEUTICALS (CHINA): NET SALES, 2020-2022*?($MILLION)
FIGURE 34. SINOPHARM PHARMACEUTICALS (CHINA): REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 35. SINOPHARM PHARMACEUTICALS (CHINA): REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 36. SHANGHAI INSTITUTE OF MATERIA MEDICA (CHINA): NET SALES, 2020-2022*?($MILLION)
FIGURE 37. SHANGHAI INSTITUTE OF MATERIA MEDICA (CHINA): REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 38. SHANGHAI INSTITUTE OF MATERIA MEDICA (CHINA): REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 39. GUANGZHOU YEED MEDICAL TECHNOLOGY CO LTD (CHINA): NET SALES, 2020-2022*?($MILLION)
FIGURE 40. GUANGZHOU YEED MEDICAL TECHNOLOGY CO LTD (CHINA): REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 41. GUANGZHOU YEED MEDICAL TECHNOLOGY CO LTD (CHINA): REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 42. SHANGHAI PHARMACEUTICAL GROUP CO LTD (CHINA): NET SALES, 2020-2022*?($MILLION)
FIGURE 43. SHANGHAI PHARMACEUTICAL GROUP CO LTD (CHINA): REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 44. SHANGHAI PHARMACEUTICAL GROUP CO LTD (CHINA): REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 45. CSPC PHARMACEUTICAL GROUP (CHINA): NET SALES, 2020-2022*?($MILLION)
FIGURE 46. CSPC PHARMACEUTICAL GROUP (CHINA): REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 47. CSPC PHARMACEUTICAL GROUP (CHINA): REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 48. JUBILANT BIOSYS (INDIA): NET SALES, 2020-2022*?($MILLION)
FIGURE 49. JUBILANT BIOSYS (INDIA): REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 50. JUBILANT BIOSYS (INDIA): REVENUE SHARE, BY GEOGRAPHY, 2022 (%)

List of Tables

LIST OF TABLES
TABLE 01. CHINA RADIOPHARMACEUTICALS MARKET, BY RADIOISOTOPE, 2022-2032 ($MILLION)
TABLE 02. CHINA RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 03. CHINA RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 04. CHINA RADIOPHARMACEUTICALS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 05. IBA MOLECULAR (BELGIUM): KEY EXECUTIVES
TABLE 06. IBA MOLECULAR (BELGIUM): COMPANY SNAPSHOT
TABLE 07. IBA MOLECULAR (BELGIUM): OPERATING SEGMENTS
TABLE 08. IBA MOLECULAR (BELGIUM): PRODUCT PORTFOLIO
TABLE 09. IBA MOLECULAR (BELGIUM): KEY STRATERGIES
TABLE 10. AECI NUCLEAR PRODUCTS (SOUTH AFRICA): KEY EXECUTIVES
TABLE 11. AECI NUCLEAR PRODUCTS (SOUTH AFRICA): COMPANY SNAPSHOT
TABLE 12. AECI NUCLEAR PRODUCTS (SOUTH AFRICA): OPERATING SEGMENTS
TABLE 13. AECI NUCLEAR PRODUCTS (SOUTH AFRICA): PRODUCT PORTFOLIO
TABLE 14. AECI NUCLEAR PRODUCTS (SOUTH AFRICA): KEY STRATERGIES
TABLE 15. INSTITUTE OF RADIOPHARMACEUTICALS (CHINA): KEY EXECUTIVES
TABLE 16. INSTITUTE OF RADIOPHARMACEUTICALS (CHINA): COMPANY SNAPSHOT
TABLE 17. INSTITUTE OF RADIOPHARMACEUTICALS (CHINA): OPERATING SEGMENTS
TABLE 18. INSTITUTE OF RADIOPHARMACEUTICALS (CHINA): PRODUCT PORTFOLIO
TABLE 19. INSTITUTE OF RADIOPHARMACEUTICALS (CHINA): KEY STRATERGIES
TABLE 20. BEIJING BEIGENE MOLECULAR PROBES CO LTD (CHINA): KEY EXECUTIVES
TABLE 21. BEIJING BEIGENE MOLECULAR PROBES CO LTD (CHINA): COMPANY SNAPSHOT
TABLE 22. BEIJING BEIGENE MOLECULAR PROBES CO LTD (CHINA): OPERATING SEGMENTS
TABLE 23. BEIJING BEIGENE MOLECULAR PROBES CO LTD (CHINA): PRODUCT PORTFOLIO
TABLE 24. BEIJING BEIGENE MOLECULAR PROBES CO LTD (CHINA): KEY STRATERGIES
TABLE 25. SINOPHARM PHARMACEUTICALS (CHINA): KEY EXECUTIVES
TABLE 26. SINOPHARM PHARMACEUTICALS (CHINA): COMPANY SNAPSHOT
TABLE 27. SINOPHARM PHARMACEUTICALS (CHINA): OPERATING SEGMENTS
TABLE 28. SINOPHARM PHARMACEUTICALS (CHINA): PRODUCT PORTFOLIO
TABLE 29. SINOPHARM PHARMACEUTICALS (CHINA): KEY STRATERGIES
TABLE 30. SHANGHAI INSTITUTE OF MATERIA MEDICA (CHINA): KEY EXECUTIVES
TABLE 31. SHANGHAI INSTITUTE OF MATERIA MEDICA (CHINA): COMPANY SNAPSHOT
TABLE 32. SHANGHAI INSTITUTE OF MATERIA MEDICA (CHINA): OPERATING SEGMENTS
TABLE 33. SHANGHAI INSTITUTE OF MATERIA MEDICA (CHINA): PRODUCT PORTFOLIO
TABLE 34. SHANGHAI INSTITUTE OF MATERIA MEDICA (CHINA): KEY STRATERGIES
TABLE 35. GUANGZHOU YEED MEDICAL TECHNOLOGY CO LTD (CHINA): KEY EXECUTIVES
TABLE 36. GUANGZHOU YEED MEDICAL TECHNOLOGY CO LTD (CHINA): COMPANY SNAPSHOT
TABLE 37. GUANGZHOU YEED MEDICAL TECHNOLOGY CO LTD (CHINA): OPERATING SEGMENTS
TABLE 38. GUANGZHOU YEED MEDICAL TECHNOLOGY CO LTD (CHINA): PRODUCT PORTFOLIO
TABLE 39. GUANGZHOU YEED MEDICAL TECHNOLOGY CO LTD (CHINA): KEY STRATERGIES
TABLE 40. SHANGHAI PHARMACEUTICAL GROUP CO LTD (CHINA): KEY EXECUTIVES
TABLE 41. SHANGHAI PHARMACEUTICAL GROUP CO LTD (CHINA): COMPANY SNAPSHOT
TABLE 42. SHANGHAI PHARMACEUTICAL GROUP CO LTD (CHINA): OPERATING SEGMENTS
TABLE 43. SHANGHAI PHARMACEUTICAL GROUP CO LTD (CHINA): PRODUCT PORTFOLIO
TABLE 44. SHANGHAI PHARMACEUTICAL GROUP CO LTD (CHINA): KEY STRATERGIES
TABLE 45. CSPC PHARMACEUTICAL GROUP (CHINA): KEY EXECUTIVES
TABLE 46. CSPC PHARMACEUTICAL GROUP (CHINA): COMPANY SNAPSHOT
TABLE 47. CSPC PHARMACEUTICAL GROUP (CHINA): OPERATING SEGMENTS
TABLE 48. CSPC PHARMACEUTICAL GROUP (CHINA): PRODUCT PORTFOLIO
TABLE 49. CSPC PHARMACEUTICAL GROUP (CHINA): KEY STRATERGIES
TABLE 50. JUBILANT BIOSYS (INDIA): KEY EXECUTIVES
TABLE 51. JUBILANT BIOSYS (INDIA): COMPANY SNAPSHOT
TABLE 52. JUBILANT BIOSYS (INDIA): OPERATING SEGMENTS
TABLE 53. JUBILANT BIOSYS (INDIA): PRODUCT PORTFOLIO
TABLE 54. JUBILANT BIOSYS (INDIA): KEY STRATERGIES